Apollo Endosurgery, Inc. (APEN) financial statements (2021 and earlier)

Company profile

Business Address 1120 SOUTH CAPITAL OF TX HWY
AUSTIN, TX 78746
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3630243119917
Cash and cash equivalents3630243119917
Receivables8911121101
Inventory, net of allowances, customer advances and progress billings109101412  
Inventory109101412  
Other undisclosed current assets4331200
Total current assets:5951485844918
Noncurrent Assets
Property, plant and equipment 767700
Intangible assets, net (including goodwill)111315435022
Goodwill55577  
Intangible assets, net (excluding goodwill)6810364322
Restricted cash and investments11111  
Other noncurrent assets0340100
Other undisclosed noncurrent assets6      
Total noncurrent assets:192426515923
TOTAL ASSETS:7775741091021221
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities111824261214
Accounts payable4101518503
Accrued liabilities7898700
Employee-related liabilities     11
Debt134     
Due to related parties    9  
Deferred revenue and credits  00
Total current liabilities:125324262014
Noncurrent Liabilities
Long-term debt and lease obligation5719213339  
Long-term debt, excluding current maturities5719213339  
Liabilities, other than long-term debt2     0
Deferred revenue and credits   0
Other liabilities2      
Other undisclosed noncurrent liabilities 1    1
Total noncurrent liabilities:5920213339 1
Total liabilities:717246596015
Stockholders' equity
Stockholders' equity attributable to parent, including:722950421116
Common stock0000000
Additional paid in capital2772512492251918782
Accumulated other comprehensive income32321  
Accumulated deficit(273)(250)(223)(177)(150)(76)(66)
Warrants and rights outstanding      1
Other undisclosed stockholders' equity attributable to parent      (1)
Total stockholders' equity:722950421116
TOTAL LIABILITIES AND EQUITY:7775741091021221

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues425161646525
Cost of revenue(20)(25)(28)(25)(25)  
Gross profit:222633404025
Operating expenses(38)(49)(73)(62)(60)(12)(23)
Operating loss:(16)(24)(40)(22)(21)(11)(18)
Nonoperating income (expense)(1)0(1)(0)(2)01
Other nonoperating income (expense)(1)0(1)(0)(2)00
Interest and debt expense(5)(4)(4)(5)(18)  
Loss from continuing operations before income taxes:(22)(27)(46)(27)(41)(11)(17)
Income tax expense(0)(0)(0)(0)(0)  
Net loss attributable to parent:(23)(27)(46)(27)(41)(11)(17)
Other undisclosed net income available to common stockholders, basic     1 
Net loss available to common stockholders, diluted:(23)(27)(46)(27)(41)(10)(17)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(23)(27)(46)(27)(41)(11)(17)
Comprehensive loss:(23)(27)(46)(27)(41)(11)(17)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1(1)101  
Comprehensive loss, net of tax, attributable to parent:(21)(28)(45)(27)(40)(11)(17)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: